Amplifai Health announced the successful completion of a new funding round, receiving investments from Wa’ed by Aramco, Plug and Play, KAUST Innovation Ventures, along with existing investors Techstars and Lamarka.
This funding will support the company’s expansion after receiving approval from the Saudi Food and Drug Authority (SFDA) for TFscan, the world’s first medical device for diabetic foot screening.
TFscan offers an innovative, non-invasive solution using AI to detect early signs of diabetic foot ulcers, helping prevent amputations.
With a high prevalence of diabetes in Saudi Arabia, this device plays a crucial role in early intervention to improve patient outcomes and reduce healthcare burdens.
